Dysregulation of the KEAP1-NRF2-ARE pathway has been implicated in several dermatological disorders, including vitiligo, psoriasis, atopic dermatitis, photoaging, and radiation dermatitis. This evidence concerns the gene NFE2L2 and atopic eczema.